Inaktiver Wert

Epirus Biopharmaceuticals Inc Aktie Nasdaq

Aktien

Dauer

Zeitraum

Stil

Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016	15.03.16
Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015	16.11.15
Transcript : EPIRUS Biopharmaceuticals, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 01:20 PM	11.08.15
Transcript : EPIRUS Biopharmaceuticals, Inc., Zalicus Inc. - M&A Call	16.04.14

Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	09.10.18
Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	31.01.18
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19.01.18
Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	18.01.18
Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	11.12.17

EPIRUS Biopharmaceuticals, Inc. befindet sich im Konkursverfahren.

Sektor

	% 1. Jan.	Kap.
MODERNA, INC.	+25.69%	48.09 Mrd.
LONZA GROUP AG	+46.90%	40.62 Mrd.
IQVIA HOLDINGS INC.	-3.46%	40.43 Mrd.
CELLTRION, INC.	-6.20%	28.36 Mrd.
ICON PUBLIC LIMITED COMPANY	+9.17%	24.89 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.01 Mrd.
MEDPACE HOLDINGS, INC.	+28.07%	12.09 Mrd.
BIO-TECHNE CORPORATION	+0.17%	11.88 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.8 Mrd.